IMIDAZOPYRAZINOL DERIVATIVES FOR THE TREATMENT OF CANCERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110046144A1
SERIAL NO

12863206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

are defined herein, inhibit the IGF-IR enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSI PHARMACEUTICALS INC106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mulvihill, Mark J Melville, US 30 121

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation